Amarin Corp Plc (AMRN)

[FishyFingers]

Yes, thanks. I am aware it is approved for the pissy little hypertriglyceridemia MARINE indication, generating a whopping 13k scripts/week. Its the ANCHOR indication that concerns me as its estimated to be 10x the size of the MARINE indication. A 1st amendment victory is better than nothing but I would still rather approval in some form or other, be it for high trigs or non-HDL-C. I fail to see why the FDA cant approve Vascepa for the ANCHOR indication - the disclaimer re unproven CV benefit is already on the label. If they cant approve that, then why not approve it as a non-HDL-C lowering agent? What the hell is the problem?